Beijing Beilu Pharmaceutical Co., Ltd.
As of 17 November 2026, for the company name Beijing Beilu Pharmaceutical Co., Ltd. as recorded, 7 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 36 records, across 25 drug names; since 21 August 2026, the records list Accepted: 2 applications, No longer listed under review: 1 application; the chemical-drug catalogue lists 27 active records with this name as holder; 19 active API registrations list this name as first registered company; 6 further acceptance records name it after the first applicant.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/17.
Drug filings
36 acceptance records as first applicant, grouped into 25 source drug names. Source data as of 2026/11/17.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Iohexol Injection 5 records · Latest accepted 2026/10/27
Supplement · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2650212 | Supplement | 2026/10/27 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2650211 | Supplement | 2026/10/27 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2500255 | Supplement | 2025/02/08 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2300588 | Supplement | 2023/03/22 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2102448 | Supplement | 2021/12/28 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
Gadoteridol Injection 2 records · Latest accepted 2026/03/04
Generic · 2
Ioversol Injection 1 records · Latest accepted 2026/01/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600053 | Supplement | 2026/01/13 | Beijing Beilu Pharmaceutical Co., Ltd.; Chengdu Brilliant Pharmaceutical Co., Ltd. | CDE ↗ |
Iobitridol Injection 2 records · Latest accepted 2025/10/14
Generic · 2
米格列醇片 · No verified English name 1 records · Latest accepted 2025/07/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502479 | Generic | 2025/07/11 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
Bimatoprost Eye Drops 1 records · Latest accepted 2025/06/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502196 | Generic | 2025/06/19 | Beijing Beilu Pharmaceutical Co., Ltd.; Jin Yao Yong Guang (Hebei) Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Upadacitinib Sustained-release Tablets 1 records · Latest accepted 2025/06/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502132 | Generic | 2025/06/14 | Beijing Beilu Pharmaceutical Co., Ltd.; Hu Zhou Ya Se Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Iopamidol Injection 2 records · Latest accepted 2025/05/16
Supplement · 2
Vonoprazan Fumarate Tablets 2 records · Latest accepted 2024/12/09
Generic · 2
Mupirocin Ointment 1 records · Latest accepted 2024/11/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403795 | Generic | 2024/11/07 | Beijing Beilu Pharmaceutical Co., Ltd.; Jiangsu Ziyond Pharmaceutical Co., Ltd. | CDE ↗ |
Tranexamic Acid Tablets 1 records · Latest accepted 2024/09/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402988 | Generic | 2024/09/10 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
Sildenafil Citrate Oral Disintegrating Tablets 1 records · Latest accepted 2024/08/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402758 | Generic | 2024/08/23 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
Iopromide Injection 1 records · Latest accepted 2024/08/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402660 | Generic | 2024/08/15 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
Iomeprol Injection 1 records · Latest accepted 2024/06/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401810 | Generic | 2024/06/18 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
Gadopentetic Acid Dimeglumine Salt Injection 3 records · Latest accepted 2024/05/17
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400664 | Supplement | 2024/05/17 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2350390 | Supplement | 2023/04/26 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2350389 | Supplement | 2023/04/26 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
Pioglitazone and Metformin Hydrochloride Tablets 1 records · Latest accepted 2024/04/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401078 | Generic | 2024/04/11 | Beijing Beilu Pharmaceutical Co., Ltd.; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | CDE ↗ |
九味镇心颗粒 · No verified English name 1 records · Latest accepted 2024/01/29
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2400167 | Supplement | 2024/01/29 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
复方聚乙二醇电解质散(III) · No verified English name 1 records · Latest accepted 2023/08/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302119 | Generic | 2023/08/15 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
西甲硅油乳剂 · No verified English name 1 records · Latest accepted 2023/07/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302027 | Generic | 2023/07/29 | Beijing Beilu Pharmaceutical Co., Ltd.; Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Gadobutrol Injection 1 records · Latest accepted 2023/05/17
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301081 | Supplement | 2023/05/17 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
Gadoteric Acid Meglumine Salt Injection 1 records · Latest accepted 2023/02/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300651 | Generic | 2023/02/27 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
Gadobenate Dimeglumine Injection 1 records · Latest accepted 2023/01/19
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350081 | Supplement | 2023/01/19 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
Paroxetine Hydrochloride Enteric-Coated Sustained-Release Tablets 1 records · Latest accepted 2022/09/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201525 | Generic | 2022/09/15 | Beijing Beilu Pharmaceutical Co., Ltd.; Guangzhou Bo Si Tao Kong Shi Pharma Co., Ltd. romanized | CDE ↗ |
Repaglinide Tablets 1 records · Latest accepted 2022/07/21
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250454 | Supplement | 2022/07/21 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
Pramipexole Dihydrochloride Prolonged-release Tablets 2 records · Latest accepted 2021/09/06
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101674 | Generic | 2021/09/06 | Beijing Beilu Pharmaceutical Co., Ltd.; Li Pin Pharma (Xiamen) Co., Ltd. romanized | CDE ↗ |
| CYHS2101673 | Generic | 2021/09/06 | Beijing Beilu Pharmaceutical Co., Ltd.; Li Pin Pharma (Xiamen) Co., Ltd. romanized | CDE ↗ |
Changes in the last 90 days
3 events from 2026/08/21 to 2026/11/18. CDE data as of 2026/11/17; NMPA data as of 2026/11/17.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Accepted: 2 applicationsNo longer listed under review: 1 application
- 2026/11/14No longer listed under review
米格列醇片 · No verified English name
CYHS2502479
Fact date: 2026/11/14 · Date added to this site: 2026/11/14
Accepted: 2025/07/11
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/10/27Accepted
Iohexol Injection
CYHB2650212
Fact date: 2026/10/27 · Date added to this site: 2026/10/28
View source ↗ - 2026/10/27Accepted
Iohexol Injection
CYHB2650211
Fact date: 2026/10/27 · Date added to this site: 2026/10/28
View source ↗
Under review
7 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/17.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Iohexol Injection | CYHB2650212 | Supplement | 2026/10/27 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Iohexol Injection | CYHB2650211 | Supplement | 2026/10/27 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Gadoteridol Injection | CYHS2600610 | Generic | 2026/03/04 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Gadoteridol Injection | CYHS2600609 | Generic | 2026/03/04 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Iobitridol Injection | CYHS2503674 | Generic | 2025/10/14 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Iobitridol Injection | CYHS2503673 | Generic | 2025/10/14 | Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Upadacitinib Sustained-release Tablets | CYHS2502132 | Generic | 2025/06/14 | Beijing Beilu Pharmaceutical Co., Ltd.; Hu Zhou Ya Se Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Catalogue holder records
27 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/17. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Vonoprazan Fumarate Tablets | Beijing Beilu Pharmaceutical Co., Ltd. | Beijing Beilu Pharmaceutical Co., Ltd. | 国药准字H20264900 | 2026/06/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vonoprazan Fumarate Tablets | Beijing Beilu Pharmaceutical Co., Ltd. | Beijing Beilu Pharmaceutical Co., Ltd. | 国药准字H20264899 | 2026/06/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ioversol Injection | Beijing Beilu Pharmaceutical Co., Ltd. | Chengdu Brilliant Pharmaceutical Co., Ltd. | 国药准字H20264260 | 2026/05/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Iopromide Injection | Beijing Beilu Pharmaceutical Co., Ltd. | Beijing Beilu Pharmaceutical Co., Ltd. | 国药准字H20263468 | 2026/02/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sildenafil Citrate Oral Disintegrating Tablets | Beijing Beilu Pharmaceutical Co., Ltd. | Beijing Beilu Pharmaceutical Co., Ltd. | 国药准字H20256390 | 2025/12/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 吡格列酮二甲双胍片(15mg/500mg) · No verified English name | Beijing Beilu Pharmaceutical Co., Ltd. | Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | 国药准字H20256205 | 2025/12/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Iomeprol Injection | Beijing Beilu Pharmaceutical Co., Ltd. | Beijing Beilu Pharmaceutical Co., Ltd. | 国药准字H20255838 | 2025/11/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 复方聚乙二醇电解质散(III) · No verified English name | Beijing Beilu Pharmaceutical Co., Ltd. | Beijing Beilu Pharmaceutical Co., Ltd. | 国药准字H20253365 | 2025/02/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | Beijing Beilu Pharmaceutical Co., Ltd. | Beijing Beilu Pharmaceutical Co., Ltd. | 国药准字H20013088 | 2024/10/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | Beijing Beilu Pharmaceutical Co., Ltd. | Beijing Beilu Pharmaceutical Co., Ltd. | 国药准字H10860002 | 2024/10/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Gadoteric Acid Meglumine Salt Injection | Beijing Beilu Pharmaceutical Co., Ltd. | Beijing Beilu Pharmaceutical Co., Ltd. | 国药准字H20244344 | 2024/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Paroxetine Hydrochloride Enteric-Coated Sustained-Release Tablets | Beijing Beilu Pharmaceutical Co., Ltd. | Guangzhou Bo Si Tao Kong Shi Pharma Co., Ltd. romanized | 国药准字H20243634 | 2024/04/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gadobutrol Injection | Beijing Beilu Pharmaceutical Co., Ltd. | Beijing Beilu Pharmaceutical Co., Ltd. | 国药准字H20247072 | 2024/04/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gadobenate Dimeglumine Injection | Beijing Beilu Pharmaceutical Co., Ltd. | Beijing Beilu Pharmaceutical Co., Ltd. | 国药准字H20203008 | 2024/03/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Pramipexole Dihydrochloride Prolonged-release Tablets | Beijing Beilu Pharmaceutical Co., Ltd. | Li Pin Pharma (Xiamen) Co., Ltd. romanized | 国药准字H20233828 | 2023/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pramipexole Dihydrochloride Prolonged-release Tablets | Beijing Beilu Pharmaceutical Co., Ltd. | Li Pin Pharma (Xiamen) Co., Ltd. romanized | 国药准字H20233827 | 2023/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Repaglinide Tablets | Beijing Beilu Pharmaceutical Co., Ltd. | Beijing Beilu Pharmaceutical Co., Ltd. | 国药准字H20113380 | 2023/05/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Gadobutrol Injection | Beijing Beilu Pharmaceutical Co., Ltd. | Beijing Beilu Pharmaceutical Co., Ltd. | 国药准字H20223177 | 2022/03/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Iopamidol Injection | Beijing Beilu Pharmaceutical Co., Ltd. | Beijing Beilu Pharmaceutical Co., Ltd. | 国药准字H20153103 | 2022/02/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Iopamidol Injection | Beijing Beilu Pharmaceutical Co., Ltd. | Beijing Beilu Pharmaceutical Co., Ltd. | 国药准字H20184113 | 2022/02/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Repaglinide Tablets | Beijing Beilu Pharmaceutical Co., Ltd. | Beijing Beilu Pharmaceutical Co., Ltd. | 国药准字H20217135 | 2021/12/13 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | Beijing Beilu Pharmaceutical Co., Ltd. | Beijing Beilu Pharmaceutical Co., Ltd. | 国药准字H10960045 | 2021/07/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Gadopentetic Acid Dimeglumine Salt Injection | Beijing Beilu Pharmaceutical Co., Ltd. | Beijing Beilu Pharmaceutical Co., Ltd. | 国药准字H10860001 | 2021/07/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Iodixanol Injection | Beijing Beilu Pharmaceutical Co., Ltd. | Beijing Beilu Pharmaceutical Co., Ltd. | 国药准字H20113465 | 2021/05/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Iodixanol Injection | Beijing Beilu Pharmaceutical Co., Ltd. | Beijing Beilu Pharmaceutical Co., Ltd. | 国药准字H20153001 | 2021/05/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Iohexol Injection | Beijing Beilu Pharmaceutical Co., Ltd. | Beijing Beilu Pharmaceutical Co., Ltd. | 国药准字H19980218 | 2021/04/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Iohexol Injection | Beijing Beilu Pharmaceutical Co., Ltd. | Beijing Beilu Pharmaceutical Co., Ltd. | 国药准字H20053800 | 2021/04/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
19 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/17.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 盐酸苯海索 · No verified English name | Beijing Beilu Pharmaceutical Co., Ltd. | Y20260000027 | I | 2026/01/29 | CDE ↗ |
| 维生素A棕榈酸酯 · No verified English name | Beijing Beilu Pharmaceutical Co., Ltd. | Y20250001424 | I | 2025/12/29 | CDE ↗ |
| 乌帕替尼 · No verified English name | Beijing Beilu Pharmaceutical Co., Ltd. | Y20250001383 | I | 2025/12/25 | CDE ↗ |
| 消旋α-生育酚 · No verified English name | Beijing Beilu Pharmaceutical Co., Ltd. | Y20250001334 | I | 2025/12/11 | CDE ↗ |
| 钆特醇 · No verified English name | Beijing Beilu Pharmaceutical Co., Ltd. | Y20250001318 | I | 2025/12/08 | CDE ↗ |
| 二硫化硒 · No verified English name | Beijing Beilu Pharmaceutical Co., Ltd. | Y20250001261 | I | 2025/11/27 | CDE ↗ |
| 钆布醇 · No verified English name | Beijing Beilu Pharmaceutical Co., Ltd. | Y20240001249 | A | 2026/04/21 | CDE ↗ |
| 富马酸伏诺拉生 · No verified English name | Beijing Beilu Pharmaceutical Co., Ltd. | Y20240000988 | A | 2026/02/25 | CDE ↗ |
| 盐酸达克罗宁 · No verified English name | Beijing Beilu Pharmaceutical Co., Ltd. | Y20240000874 | A | 2026/05/12 | CDE ↗ |
| 硫酸钠 · No verified English name | Beijing Beilu Pharmaceutical Co., Ltd. | Y20230000271 | A | 2026/07/31 | CDE ↗ |
| 钆特酸葡胺 · No verified English name | Beijing Beilu Pharmaceutical Co., Ltd. | Y20220001195 | A | 2026/08/15 | CDE ↗ |
| 瑞格列奈 · No verified English name | Beijing Beilu Pharmaceutical Co., Ltd. | Y20210000275 | A | 2024/09/27 | CDE ↗ |
| 钆布醇 · No verified English name | Beijing Beilu Pharmaceutical Co., Ltd. | Y20200000909 | A | 2026/09/16 | CDE ↗ |
| 钆喷酸葡胺 · No verified English name | Beijing Beilu Pharmaceutical Co., Ltd. | Y20190009524 | A | — | CDE ↗ |
| 瑞格列奈 · No verified English name | Beijing Beilu Pharmaceutical Co., Ltd. | Y20190008297 | A | — | CDE ↗ |
| 碘海醇 · No verified English name | Beijing Beilu Pharmaceutical Co., Ltd. | Y20190008250 | A | 2023/03/24 | CDE ↗ |
| 格列美脲 · No verified English name | Beijing Beilu Pharmaceutical Co., Ltd. | Y20190007874 | A | — | CDE ↗ |
| 钆喷酸葡胺 · No verified English name | Beijing Beilu Pharmaceutical Co., Ltd. | Y20170001940 | A | 2025/01/16 | CDE ↗ |
| 钆贝葡胺 · No verified English name | Beijing Beilu Pharmaceutical Co., Ltd. | Y20170000223 | A | 2024/10/18 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
6 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/17.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 米格列醇片 · No verified English name | CYHB2601333 | Supplement | 2026/07/14 | Lu Zhi Bao Pharma Co., Ltd. romanized; Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Tranexamic Acid Tablets | CYHB2501794 | Supplement | 2025/09/09 | Hainan Yao Gu Yun Bio Technology Co., Ltd. romanized; Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ioversol Injection | CYHS2501534 | Generic | 2025/04/23 | Chengdu Tian Zhi Yi Shang Pin Pharmaceuticals Technology Co., Ltd. romanized; Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ioversol Injection | CYHS2500841 | Generic | 2025/02/25 | Chengdu Tian Zhi Yi Shang Pin Pharmaceuticals Technology Co., Ltd. romanized; Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ioversol Injection | CYHS2500626 | Generic | 2025/02/08 | Shandong Ru Zhi Biopharmaceuticals Technology Co., Ltd. romanized; Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
| 九味镇心颗粒 · No verified English name | CYZB2402361 | Supplement | 2024/11/29 | Lu Zhi Bao Pharma Co., Ltd. romanized; Beijing Beilu Pharmaceutical Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/17
- Chemical-drug catalogue
- Last successful update: 2026/11/17
- API registrations
- Last successful update: 2026/11/17
- NMPA drug delivery notices
- Last successful update: 2026/11/17
Loaded notices dated 2026-11-03 to 2026-11-17; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.